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1.Introduction:
Diabetic patients included glycemic self-monitoring convention in Belgium can benefit from a device measuring subcutaneous glucose concentration (GC) : 
FreeStyle Libre® (FSL) / Abbott . The main advantage of this technology is that it is less invasive ( blood sampling not required). It also allows patients to obtain, in 
addition to the instantaneous value of GC, retrospective kinetic data, but also prospective trend of its kinetics. In this study, we evaluated the contribution of FSL 
on the equilibration of diabetes, on the time spent in hypoglycemia and on weight. We also asked patient's satisfaction with this system. Data from 838 diabetic 
patients (type 1 or total insulin deficiency) were collected between May 2016 and October 2017, 645 patients with FSL system and 193 preferring to continue 
capillary blood samples (SMBG). In the FSL group, compared to the SMBG group, there was a slight decrease in HbA1c estimated at 0.15 ± 0.073% after 15 
months. This decrease appears mainly when the starting level is high (HbA1c> 7.5%). The body mass index (BMI) increases slightly in patients with the device 
but remains stable in subjects without FSL. Patients perform an average of 8.8 checks: the more patients perform daily scans, the greater the number of data 
included in the target, that is, the better the glycemic balance. A higher number of scans is also associated with a decrease in the average duration of 
hypoglycemia. Finally, the satisfaction survey shows a fairly high degree of patient satisfaction with the use of FSL. 




 Satisfaction : High degree of satisfaction
3.Subjects and methods:
Observational, retrospective study between July 2016 and October 
2017.
2.Goals of the study:
 Contribution of FSL on the overall equilibration 
of diabetes. 
 Contribution of FSL on the number of 
hypoglycemias.
 Contribution of FSL on body mass index (BMI). 
 We also asked patients how satisfied they 
were with this system.




645 patients with FSL 
(77%)
193 patient without FSL 
(23%)
81 patients ruled out 
because less than 2 
mesure of HbA1c
32 patients ruled out 
because diabetes start 
after 2014
37 patients excluded 
because of abandon of 
the device during the 
study
35 patients excluded 
because of the lack of 
data
Age 50 ± 14 ans 
Gender Female : 384 (46%)
Male : 454 (54%)
Type of diabètes Type 1 : 775
Type 2 : 63
Duration of diabetes 26 ± 12 years
IMC (all values ​​during the study 
period)
26 ± 3,48 kg/m2
• HbA1c decreases 0,15%
• HbA1c decreases only if 
HbA1c at the beginning is 
higher
• No change in the number of 
hypoglycemias
• Correlation between 
duration of hypoglycemias 
and number of scans
• Correlation between number 
of hypoglycemia and number 
of scans
• BMI increase 0,15 kg/m2
5. Conclusion : 
In the FSL group, compared to the SBG group, there was a slight decrease in HbA1c values witch appears  mainly when the starting level is high. 
Patients perform an average of 8.8 checks per day and a higher number of scans is associated with a decrease in the average duration of                                  
hypoglycemias.  Finally, the satisfaction survey shows  a  high degree of patient satisfaction with the use of FSL. 
4. Result (1) :
Minimum Maximum Average
Registration period (day) 6 92 64,6 ± 30,6
Number of scan/day 1 43 8,8 ± 4,8
Percentage of data 10 100 85,2 ± 18
HbA1c (%) 4,9 12,2 7,8 ± 1,17
Number of hypoglycemia 0 5,3 0,95  ± 0,94










































Average duration of hypoglycemia (minute)
